APYX compared with SOPH: revenue, margins and what each company keeps, and the suppliers and customers both name

APYXApyx Medical Corp

Mkt capRevenueRevenue

SOPHSOPHiA GENETICS SA

Mkt capRevenueRevenue

Compare

APYXApyx Medical Corp

SOPHSOPHiA GENETICS SA

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

APYX: latest quarter is a loss; flow not drawable. SOPH: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only APYX 2

—Gmed SASunlistedsupplier

—Symmetry Surgicalunlistedcustomer

Shared 0

No disclosed counterparties: SOPH.

Only SOPH 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

APYX, solidSOPH, dashed

APYXApyx Medical Corp

2.55· pre 2.55· delayed

Mkt cap$109.5MRevenue$14MQ2 FY26Revenue$53MFY25

SOPHSOPHiA GENETICS SA

7.62· pre 7.62· delayed

Pre-marketOct 30 '26delayed

Mkt cap$522.6MRevenue—Revenue—

Compare

Pre-marketOct 30 '26delayed

APYXApyx Medical Corp

SOPHSOPHiA GENETICS SA

2.55pre 2.55delayed

Price

7.62pre 7.62delayed

$109.5M

Mkt cap

$522.6M

Q2 FY26$14M

Revenue

—

FY25$53M

Revenue

—

APYX2.55vsSOPH7.62Pre-marketOct 30 '26delayed